MedPath

The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

Completed
Conditions
Osteoporosis, Postmenopausal
Interventions
Other: Fracture evaluation
Registration Number
NCT01381588
Lead Sponsor
GlaxoSmithKline
Brief Summary

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled.

Detailed Description

This is an observational study to investigate the prevalence of osteoporotic fractures in post menopausal patients. Post menopausal patients who visit OS(orthopedic surgery) including GHs(general hospitals) and clinics will be enrolled. They will take the evaluation of spine X-ray and answer to a few questions. Their medical record will be reviewed and relevant clinical findings will be collected.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1136
Inclusion Criteria
  • Subjects who were diagnosed post menopausal state
  • Subjects over 50 years old
  • The Definition of Post Menopause Women : Women whose last menstruation was over 12months ago
  • Subjects who visit orthopedic surgery
  • Subjects who have informed consents
Exclusion Criteria
  • Subjects who are not confirmed as post menopause state
  • Subjects who do not understand the contents of questionnaire
  • Subjects over 80 years old
  • Subjects experienced any high energy fracture (including trash and fall) within 3 months.
  • Subjects experienced a fracture except vertebral fracture within 6 months
  • Unable to evaluate L-spine BMD over 2 levels because of spinal fracture or instrumentation for L-spine 1-4.
  • Unable to evaluate BMD at both femur because of hip fracture or instrumentation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Post menopausal womenFracture evaluationPost menopausal women between 50 to 80
Primary Outcome Measures
NameTimeMethod
The prevalence of OVCFs confirmed by history and X-ray1 day
Secondary Outcome Measures
NameTimeMethod
The prevalence of asymptomatic (or missed) fractures1 day

Trial Locations

Locations (1)

GSK Investigational Site

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath